| CDK4/6 inhibitors impair recovery from cytotoxic chemotherapy in pancreatic adenocarcinoma B Salvador-Barbero, M Álvarez-Fernández, E Zapatero-Solana, ... Cancer cell 37 (3), 340-353. e6, 2020 | 139 | 2020 |
| Therapeutic relevance of the PP2A-B55 inhibitory kinase MASTL/Greatwall in breast cancer M Álvarez-Fernández, M Sanz-Flores, B Sanz-Castillo, M Salazar-Roa, ... Cell Death & Differentiation, 1-13, 2017 | 90 | 2017 |
| Oxidative stress and mitochondrial dysfunction in Kindler syndrome E Zapatero-Solana, JL García-Giménez, S Guerrero-Aspizua, M García, ... Orphanet Journal of Rare Diseases 9, 1-10, 2014 | 24 | 2014 |
| Transient exposure to miR‐203 enhances the differentiation capacity of established pluripotent stem cells M Salazar‐Roa, M Trakala, M Álvarez‐Fernández, F Valdés‐Mora, ... The EMBO Journal 39 (16), e104324, 2020 | 17 | 2020 |
| Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy NPJ Breast Cancer 8, 2022 | 7 | 2022 |
| Author Correction: Crystal structure of active CDK4-cyclin D and mechanistic basis for abemaciclib efficacy SI Gharbi, LA Pelletier, A Espada, J Gutiérrez, SMG Sanfeliciano, ... NPJ Breast Cancer 8, 2022 | | 2022 |
| Translating Regenerative Medicine to the Clinic. Translational Medicine Series. J. Laurence S Guerrero-Aspizua, CJ Conti, E Zapatero-Solana, F Larcher, M Del Río Academic Press Inc. II, 2015 | | 2015 |
